Europe – Page 64 – pharmaceutical daily

July 18, 2019 Off

Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors

Inflection Biosciences (Inflection), a company developing innovative therapeutics for the treatment of cancer, and AUM Biosciences (AUM), a company focused on the development of innovative and affordable oncology medicines with high unmet medical need in Asia, today announced a global license agreement for Inflection’s first-in-class PIM/PI3K/mTOR inhibitors.

July 16, 2019 Off

Results: Arbutus Biopharma’s AB-506 is a potent capsid inhibitor

By Dino Mustafić

Arbutus Biopharma’s AB-506 is a potent oral capsid inhibitor, preliminary results from testing have shown, the company said Monday.

July 11, 2019 Off

Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being

By BusinessWire

Microphyt secures one of the largest fundraising in the microalgae sector; The round was co-led by Sofinnova Partners and Bpifrance…

July 11, 2019 Off

Gerresheimer quarterly net income up to €47.1M

By Dino Mustafić

Gerresheimer AG has had a successful second quarter, en route to meeting all of its targets for 2019, Dietmar Siemssen, the CEO, has said in a press release Tursday.

July 11, 2019 Off

Tilray® Imports GMP-Certified Standardized Medical Cannabis Oil Into Ireland

By BusinessWire

Ireland becomes the 13th country with Tilray medical cannabis products as company continues global expansion in Europe and increases access to patients in need

July 10, 2019 Off

BioNTech Raises $325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline

By BusinessWire

BioNTech pulled one of the largest private EU biotech funding events expands global shareholder base with $325 from investors

July 9, 2019 Off

Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being

By BusinessWire

Microphyt secures one of the largest fundraising in the microalgae sector; The round was co-led by Sofinnova Partners and Bpifrance…

July 9, 2019 Off

Neovacs gets payment for AllergyVacs, from National Agency for Research

By Dino Mustafić

Neovacs has received a first payment of a total amount up to €702.000, for its preclinical development program AllergyVacs, within the grant awarded by the National Agency for Research (ANR), conducted in collaboration with Inserm and the Immunology and Allergy Department of Pasteur Institute.

July 9, 2019 Off

Dilafor enrolls the first patient to test tafoxiparin in certain pregnant women

By Dino Mustafić

Karolinska Development’s drug developer Dilafor AB, focused on tafoxiparin for obstetric indications, has enrolled the first subject in its Phase 2b study with tafoxiparin in pregnant women planned for labor induction, Karolinska said Tuesday in a press release.

July 9, 2019 Off

Dr. Reddy’s Announces the Launch of the Over-the-counter Store Brand Equivalent of Mucinex® D Extended Release Tablets in Two Strengths in the U.S. Market

By BusinessWire

Dr. Reddy’s Laboratories today announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets